Dr. Forrest Craig Conrath , MD
Specialist • Reno, NV
5423 Reno Corporate Dr.
Reno, NV 895112250
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 6, 2006; this date does not establish years in practice.
-
Published CMS data list 12,804 Original Medicare Part B services in 2018.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2018. Published rows only; this is not a quality measure.
-
Published Part B service records, 2018:
- J0897 — Injection, denosumab, 1 mg: 5,460 service units.
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg: 1,268 service units.
- 85025 — Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count: 1,140 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2018. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2017 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2018). CPT notice
See all 30 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 91 Medicare Part D prescriptions, including refills, in 2019.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019. Published rows only; this is not a quality measure.
-
Published Part D records, 2019:
- Anastrozole — 63 prescription fills, including refills.
- Hydroxyurea — 28 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 23,140 in 2017 to 12,804 in 2018.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2018.
Practice Location & Contact Primary Location
5423 Reno Corporate Dr.
Reno, NV 895112250
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
485 people with Original Medicare in 2018
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2018.
Medicare-allowed amount
About $482,954 in 2018
The total amount Medicare approved for these services in 2018. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2018.
Paid by Medicare
About $379,505 in 2018
The part of the Medicare-allowed amount that Medicare itself paid in 2018, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2018.
30-day fills
192 standardized 30-day fills in 2019
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,860 in 2019
The total cost of these prescriptions in 2019, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $28.07 in 2022
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2022.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Reno and Nevada
Billing and prescribing volume is not a quality rating.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Conrath are from 2018.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Conrath are from 2019.
61 active clinicians are listed under Specialist with a practice address in Reno, NV (284 in Nevada).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Reno
3.3% of these 61 clinicians have the CMS telehealth indicator.
16.4% of these 61 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 45% from 23,140 in 2017 to 12,804 in 2018.
- 2017: 23,140
- 2018: 12,804
-
Medicare-allowed amount
Medicare-allowed amount decreased 55% from $1,079,076 in 2017 to $482,954 in 2018.
- 2017: $1,079,076
- 2018: $482,954
-
Paid by Medicare
Paid by Medicare decreased 56% from $854,217 in 2017 to $379,505 in 2018.
- 2017: $854,217
- 2018: $379,505
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 94% from 1,438 in 2015 to 91 in 2019.
- 2015: 1,438
- 2016: 1,482
- 2017: 1,220
- 2018: 1,067
- 2019: 91
-
30-day fills
30-day fills decreased 90% from 1,845 in 2015 to 192 in 2019.
- 2015: 1,845
- 2016: 1,964
- 2017: 1,728
- 2018: 1,627
- 2019: 192
-
Part D drug cost
Part D drug cost decreased 100% from $951,164 in 2015 to $2,860 in 2019.
- 2015: $951,164
- 2016: $1,562,208
- 2017: $1,948,561
- 2018: $1,892,518
- 2019: $2,860
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2022 only.
Sources: CMS Medicare Physician & Other Practitioners (2018), CMS Medicare Part D Prescribers (2019), CMS Open Payments (2022), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2022 (payments made January 1 – December 31, 2022): fewer than 11 records totaling $28.07.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $28.07 |
Source: CMS Open Payments, program year 2022, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2017 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2018; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
5,460 | 18 | $53.55 | $17.66 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
1,268 | 61 | $1.00 | $0.11 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
1,140 | 324 | $30.34 | $9.25 |
|
J9395
Injection, fulvestrant, 25 mg
|
840 | 12 | $290.00 | $95.70 |
|
J2469
Injection, palonosetron hcl, 25 mcg
|
800 | 46 | $61.36 | $19.32 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
620 | 255 | $330.00 | $106.79 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
594 | 254 | $225.00 | $72.86 |
|
96375
Injection of additional new drug or substance into vein
|
337 | 79 | $55.00 | $18.05 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
277 | 93 | $440.00 | $143.65 |
|
J9190
Injection, fluorouracil, 500 mg
|
228 | 14 | $7.08 | $1.57 |
|
J9201
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
|
183 | 12 | $113.00 | $6.24 |
|
36415
Insertion of needle into vein for collection of blood sample
|
155 | 104 | $9.00 | $2.92 |
|
96372
Injection of drug or substance under skin or into muscle
|
150 | 46 | $65.00 | $20.72 |
|
96415
Administration of chemotherapy into vein, each additional hour
|
119 | 36 | $96.00 | $31.36 |
|
J1200
Injection, diphenhydramine hcl, up to 50 mg
|
92 | 40 | $4.00 | $0.58 |
|
96367
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
|
59 | 30 | $95.00 | $31.88 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
57 | 16 | $95.00 | $31.24 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
53 | 20 | $220.00 | $73.95 |
|
96366
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
|
53 | 11 | $60.00 | $22.20 |
|
96417
Administration of additional new drug or substance into vein, 1 hour or less
|
53 | 27 | $210.00 | $68.19 |
|
J3490
Unclassified drugs
|
52 | 29 | $200.38 | $63.08 |
|
96523
Irrigation of implanted venous access drug delivery device
|
34 | 24 | $85.00 | $28.42 |
|
J7030
Infusion, normal saline solution , 1000 cc
|
30 | 13 | $9.00 | $2.50 |
|
96411
Administration of additional new drug or substance into vein using push technique
|
27 | 16 | $182.00 | $58.17 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
26 | 14 | $220.00 | $68.42 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2018; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2019.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Anastrozole | Anastrozole | 63 | 4,200 | $1,541.56 | 23 |
| Hydroxyurea | Hydroxyurea | 28 | 1,544 | $1,318.25 | 11 |
Source: CMS Part D by Provider and Drug, 2019; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.), Master of Public Health
Nurse Practitioner
Family Nurse Practitioner
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 5423 RENO CORPORATE DR., RENO, NV 895112250 (Tel: 7753290873)
NPI status registered as active in NPPES database
Registered at 236 W 6TH ST, SUITE 400, RENO, NV 895034517 (Tel: 7753290873)
Registered at 236 W 6TH ST, SUITE 400, RENO, NV 895034517 (Tel: 7753290873)
Recorded as FORREST CONRATH, M.D.
Specialist (license number reported to NPPES: NV 5454)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Specialists in Reno
- Dr. Ross Golding, MD
- Dr. Peter Lim, MD
- Dr. Galia Meiri, MD
- Dr. Phillip Dahan, MD
- Dr. Charles Virden, MD, FACS
- Dr. Terry Mccaskill, MD
Mailing Address
236 W 6th St, Suite 400
Reno, NV 895034517
Phone: 7753290873